ストックスクリーナーアプリを入手
3.17
10.96%
-0.39
アフターアワーズ：
3.11
-0.06
-1.89%
前日終値:
$3.56
開ける：
$3.41
24時間の取引高:
94,406
Relative Volume:
0.93
時価総額：
$15.36M
収益：
$8,700
当期純損益:
$-8.49M
株価収益率:
-0.643
EPS:
-4.9303
ネットキャッシュフロー:
$-7.39M
1週間 パフォーマンス:
-0.31%
1か月 パフォーマンス:
-31.24%
6か月 パフォーマンス:
+57.71%
1年 パフォーマンス:
-4.23%
1日の値動き範囲:
$3.11
$3.445
1週間の範囲:
$2.93
$3.68
52週間の値動き範囲:
$1.63
$5.25
Heartsciences Inc Stock (HSCS) Company Profile
Compare HSCS vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.17 | 15.36M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc (HSCS) 最新ニュース
One seller would hold about 94% of voting power after HeartSciences (HSCS)' proposed merger. - Stock Titan
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device (K260005) - Kalkine Media
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device Under K260005 - Kalkine Media
HeartSciences Submits Supplemental Proxy Materials Detailing Fortitude Merger and New Legal Appointment - Kalkine Media
Form S-3 HEARTSCIENCES INC. For: 25 September By Investing.com - Investing.com Canada
HeartSciences Warrant (HSCSW) Climbs 25.17% to $0.05 in Sub-Penny TradingATR Stop - dars.gov.et
HeartSciences (NASDAQ: HSCS) asks investors to back a shift into crypto mining - Stock Titan
HeartSciences Widens Q1 Loss to $3.2 Million as wavECG Device Is Shelved - Minichart
HSCS 8-K FilingsHeartSciences Inc. SEC 8-K - Stock Titan
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update - The Manila Times
HeartSciences posts $3.2M loss, cash down to $29.9K - Stock Titan
HSCS Q1'26 Earnings: EPS estimate is (0.72) USD - TradingView
HSCS Q1'26 Earnings: revenue estimate is 0 USD - TradingView
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionPositive Gamma - vinanet.vn
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionSMA Signal - dars.gov.et
HeartSciences(HSCS) Stock Options Chain | Quotes & News - Moomoo
Fortitude invests USD 1M in HeartSciences - Medical Buyer
Fortitude Mining Invests in HeartSciences Ahead Planned Merger - TipRanks
HeartSciences: Fortitude buys $1.0M of stock, merger on track as Fortitude posts $20.9M revenue, $8.5M adj. EBITDA - TradingView
Fortitude Mining reports $21M Q2 revenue and plots public listing via reverse merger - Crypto Briefing
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - marketscreener.com
Press Release: Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - Moomoo
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - businesswire.com
HeartSciences and Fortitude Mining Sign Definitive All-Stock Merger Agreement - Minichart
Form 8K HeartSciences Inc For: 19 August By Investing.com - Investing.com Nigeria
Fortitude Now Holds About 9.4% of HeartSciences' Outstanding Shares of Common Stock >HSCS - Moomoo
Fortitude Investment Strengthens HeartSciences Ahead Planned Merger - TipRanks
BRIEF-Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - Bitget
[8-K/A] HeartSciences Inc. Amends Material Event Report - Stock Titan
Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - TradingView
HeartSciences Announces $1 Million Fortitude Investment at 22% Premium Ahead of Proposed Merger - Quiver Quantitative
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingFinal Results - vinanet.vn
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingRevenue Growth Report - Vinanet
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingEstimate Dispersion - dars.gov.et
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration - The Manila Times
HeartSciences sells 411,522 shares to Fortitude in $1 million private placement at $2.43 each - Bitget
DCG stake sets up voting control of HeartSciences (HSCS) - Stock Titan
Digital Currency Group Discloses Investment at HeartSciences with 9.4% Stake - TradingView
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com South Africa
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Nigeria
HeartSciences Completes Private Placement to Support Merger - TipRanks
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com India
HeartSciences (HSCS) Holds Steady at $2.06 as Shares FlatlineETF Premium Discount - vinanet.vn
HeartSciences Inc (HSCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HeartSciences Inc. (HSCS) Holds at $2.02 After 1.00% Gain as Key Levels Remain in FocusSentiment Shift - dars.gov.et
HSCS Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue AI-ECG BurnRevenue Inflection Point - vinanet.vn
HeartSciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
HeartSciences Inc. Revenue Breakdown – BOATS:HSCSW - TradingView
Heartsciences Inc (HSCS) 財務データ
収益
当期純利益
現金流量
EPS
2.19%
5.76%
大文字化:
|
ボリューム (24 時間):